Home
Products
Learn
About
Pricing
Log In
OLMA
Asset Logo

OLEMA PHARMACEUTICALS INC

πŸ‡ΊπŸ‡Έ NYSE/NASDAQ

Compare
Add to watchlist
πŸ‘‘ Overview

πŸ“ˆ Performance

πŸ’΅ Cost

πŸƒ Esg

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

-20.15%
Annual Growth

4 years average annual capital growth

🌏

1
Pearlers Invested

Since January 2020

πŸ‘‘ Overview

Key information
πŸ”Ž Fund Overview

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. It is advancing a pipeline of novel therapies by leveraging its deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance. Its lead product candidate, palazestrant (OP-1250), is a proprietary, orally available complete estrogen receptor (ER) antagonist (CERAN) and a selective ER degrader (SERD), in a Phase 3 clinical trial called OPERA-01. It is being investigated in patients with recurrent, locally advanced or metastatic ER-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer. In addition, it is developing OP-3136, a potent KAT6 inhibitor, in a Phase 1 clinical trial. OP-3136 is a novel, orally available small molecule that potently and selectively inhibits KAT6.

πŸ“ˆ Performance

Price History*

-89.60%

1M

1Y

All Time

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

N/A
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸ€“ Advanced information

Technical Info

πŸ’° Price*

$5.04

*Price may be up to 24 hours old

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in OLMA

0

πŸ“Š Total Capital Earnings

N/A

πŸ”ƒ Average investment frequency

27 weeks

πŸ’΅ Average investment amount

$1,549

⏰ Last time a customer invested in OLMA

89 days
OLMA investor breakdown
πŸ’΅ Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

πŸ‘Ά Age of investors

18 - 25

26 - 34

35 - 90

πŸ™‹ Legal gender of investors

Female

Male

Pearlers who invest in OLMA also invest in...

Akero Therapeutics Inc

AKRO

πŸ™Œ Performance (5Yr p.a)

19.31%

πŸ“Š Share price

$43.04 USD

πŸ“ˆ HIGH PRICE GROWTH

Find Out More

πŸ“Š Share price

$1.58 USD

πŸ™Œ Performance (5Yr p.a)

-15.61%

πŸ“Š Share price

$1.60 USD

πŸ™Œ Performance (5Yr p.a)

36.24%

πŸ“Š Share price

$45.05 USD

πŸ“ˆ HIGH PRICE GROWTH

πŸ™Œ Performance (5Yr p.a)

-19.25%

πŸ“Š Share price

$0.37 USD

Want more shares? Try these...

πŸ™Œ Performance (5Yr p.a)

7.15%

πŸ“Š Share price

$22.03 USD

πŸ“ˆ HIGH PRICE GROWTH

πŸ™Œ Performance (5Yr p.a)

10.53%

πŸ“Š Share price

$105.50 USD

πŸ“ˆ HIGH PRICE GROWTH

Compare
Add to watchlist